A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
12/20/2015 | Ingunn Stromnes
A new immunotherapy approach shows that engineered T cells are able to penetrate into pancreatic tumors and directly attack the cancer
12/20/2015 | Michael Schubert
Epithelial-to-mesenchymal transition in pancreatic cancer may play a role in treatment resistance.
12/20/2015 | Anne Marie Lennon
Screening for pancreatic cysts can help with early detection and treatment – but how can we tell which lesions are benign and which may progress to cancer?
Pancreatic cancer is often treated as a homogeneous disease, but new research reveals distinct subtypes of tumor and stromal gene expression
Pancreatic cancer is a challenge to stage because there’s no good molecular imaging method – but three new antibody conjugates may change that
12/20/2015 | Christopher Chapman
Circulating tumor cells may hold information crucial for better pancreatic cancer diagnosis and treatment – but locating them needs special tactics
Pancreatic cancer is tough to understand, diagnose and treat. Undeterred researchers are on a quest to crack the case.
12/18/2015 | Xia-Jun Ma
RNA in situ hybridization offers a new way to overcome the challenges of advancing RNA cancer biomarkers to the clinic
12/18/2015 | Katherine Lau
Confocal Raman microscopy is a new, noninvasive way of obtaining morphological and chemical information about cells that may lead to better cancer research
12/18/2015 | Kathryn Largue, Daniel M. Davis
New super-resolution microscopy techniques give us better insight into how our immune cells fight cancer, and how we can help
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology